Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simak Ali

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Plos One|December 19, 2024
Correction: Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
Scientific Reports|March 23, 2024
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signalingTommaso De Marchi, Chun-Fui Lai, Georgia M Simmons, et al.
Plos One|February 12, 2016
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
Cancers|December 24, 2021
Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast CancerIsabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, et al.
Journal of the National Cancer Institute|February 16, 2013
A common deletion in the APOBEC3 genes and breast cancer riskJirong Long, Ryan J Delahanty, Guoliang Li, et al.
Oncogene|December 16, 2020
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κBManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Oncogene|July 16, 2002
Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraDongsheng Chen, Elinor Washbrook, Naveed Sarwar, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Breast Cancer Research and Treatment|March 22, 2015
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancerRezvan Abduljabbar, Methaq Mueen Al-Kaabi, Ola H Negm, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Plos One|December 19, 2024
Correction: Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
Scientific Reports|March 23, 2024
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signalingTommaso De Marchi, Chun-Fui Lai, Georgia M Simmons, et al.
Plos One|February 12, 2016
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
Cancers|December 24, 2021
Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast CancerIsabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, et al.
Journal of the National Cancer Institute|February 16, 2013
A common deletion in the APOBEC3 genes and breast cancer riskJirong Long, Ryan J Delahanty, Guoliang Li, et al.
Oncogene|December 16, 2020
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κBManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Oncogene|July 16, 2002
Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraDongsheng Chen, Elinor Washbrook, Naveed Sarwar, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Breast Cancer Research and Treatment|March 22, 2015
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancerRezvan Abduljabbar, Methaq Mueen Al-Kaabi, Ola H Negm, et al.
Pageof 12